Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia

Oncogene

Volumn 27, Issue 49, 2008, Pages 6356-6364

  Bijl, J ^a,b,c   Krosl, J ^a   Lebert Ghali, C E ^b   Vacher, J ^d   Mayotte, N ^a   Sauvageau, G ^a,b,c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Collaborator oncogenes; E2A PBX1; Hoxb4; T ALL

Indexed keywords

HOX PROTEIN; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR HOXB4; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENE INTERACTION; GENE OVEREXPRESSION; LYMPHATIC LEUKEMIA; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; TRANSGENE;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; LEUKEMIA, T-CELL; MICE; MICE, TRANSGENIC; MOLONEY MURINE LEUKEMIA VIRUS; MUTAGENESIS, INSERTIONAL; ONCOGENE PROTEINS, FUSION; TRANSCRIPTION FACTORS;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MUS; MUS MUSCULUS;

EID: 54549083348     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.233     Document Type: Article

References (45)

1. Armstrong SA, Look AT. (2005). Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 23: 6306-6315.
2. Azpiazu N, Morata G. (1998). Functional and regulatory interactions between Hox and extradenticle genes. Genes Dev 12: 261-273.
3. Bain G, Engel I, Robanus Maandag EC, Te Riele HP, Voland JR, Sharp LL et al. (1997). E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 17: 4782-4791.
4. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC et al. (1994). E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79: 885-892.
5. Bergeron J, Clappier E, Cauwelier B, Dastugue N, Millien C, Delabesse E et al. (2006). HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation. Leukemia 20: 1184-1187.
6. Bijl J, Sauvageau M, Thompson A, Sauvageau G. (2005). High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia. Genes Dev 19: 224-233.
7. Caudell D, Zhang Z, Chung YJ, Aplan PD. (2007). Expression of a CALM-AF10 fusion gene leads to Hoxa cluster over-expression and acute leukemia in transgenic mice. Cancer Res 67: 8022-8031.
8. Cauwelier B, Cave H, Gervais C, Lessard M, Barin C, Perot C et al. (2007). Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia 21: 121-128.
9. Cellot S, Krosl J, Chagraoui J, Meloche S, Humphries RK, Sauvageau G. (2007). Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells. Exp Hematol 35: 802-816.
10. Chang CP, De Vivo I, Cleary ML. (1997). The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis. Mol Cell Biol 17: 81-88.
11. Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS et al. (1993). Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74: 833-843.
12. Dik WA, Brahim W, Braun C, Asnafi V, Dastugue N, Bernard OA et al. (2005). CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia 19: 1948-1957.
13. Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ et al. (2003). Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 102: 262-268.
14. Hogan B. (1983). Molecular biology. Enhancers, chromosome position effects, and transgenic mice. Nature 306: 313-314.
15. Hough MR, Takei F, Humphries RK, Kay R. (1994). Defective development of thymocytes overexpressing the costimulatory molecule, heat-stable antigen. J Exp Med 179: 177-184.
16. Kamps MP, Baltimore D. (1993). E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol 13: 351-357.
17. Kamps MP, Murre C, Sun XH, Baltimore D. (1990). A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60: 547-555.
18. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. (1998). Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17: 3714-3725.
19. Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G. (2001). NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 20: 350-361.
20. Krosl J, Sauvageau G. (2000). AP-1 complex is effector of Hox-induced cellular proliferation and transformation. Oncogene 19: 5134-5141.
21. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. (2003). In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 9: 1428-1432.
22. LeBrun DP, Cleary ML. (1994). Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias. Oncogene 9: 1641-1647.
23. Look AT. (1997). Oncogenic transcription factors in the human acute leukemias. Science 278: 1059-1064.
24. Lu Q, Wright DD, Kamps MP. (1994). Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 14: 3938-3948.
25. Mann RS. (1995). The specificity of homeotic gene function. Bioessays 17: 855-863.
26. Medina-Martinez O, Ramirez-Solis R. (2003). In vivo mutagenesis of the Hoxb8 hexapeptide domain leads to dominant homeotic transformations that mimic the loss-of-function mutations in genes of the Hoxb cluster. Dev Biol 264: 77-90.
27. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD et al. (1990). Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60: 535-545.
28. Pineault N, Abramovich C, Ohta H, Humphries RK. (2004). Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol 24: 1907-1917.
29. Sanyal M, Tung JW, Karsunky H, Zeng H, Selleri L, Weissman IL et al. (2007). B-cell development fails in the absence of the Pbx1 proto-oncogene. Blood 109: 4191-4199.
30. Sauvageau G, Thorsteinsdottir U, Hough MR, Hugo P, Lawrence HJ, Largman C et al. (1997). Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 6: 13-22.
31. Sauvageau G, Thorsteinsdottir U, Mayotte N, Jerome LJ. (2001). Evidence that chromosome instability and stem cell expansion cooperate to induce leukemia in mice. Blood 98(Part: I): 836a.
32. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. (2005). HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 106: 274-286.
33. Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B et al. (2005). A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia 19: 358-366.
34. Su X, Drabkin H, Clappier E, Morgado E, Busson M, Romana S et al. (2006). Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer 45: 846-855.
35. Taghon T, Stolz F, De Smedt M, Cnockaert M, Verhasselt B, Plum J et al. (2002). HOX-A10 regulates hematopoietic lineage commitment: evidence for a monocyte-specific transcription factor. Blood 99: 1197-1204.
36. Taghon T, Thys K, De Smedt M, Weerkamp F, Staal FJ, Plum J et al. (2003). Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development. Leukemia 17: 1157-1163.
37. Thompson A, Quinn MF, Grimwade D, O'Neill CM, Ahmed MR, Grimes S et al. (2003). Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Blood 101: 1558-1565.
38. Thorsteinsdottir U, Krosl J, Kroon E, Haman A, Hoang T, Sauvageau G. (1999). The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. Mol Cell Biol 19: 6355-6366.
39. Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ et al. (2002). Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99: 121-129.
40. Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ et al. (1997). Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 17: 495-505.
41. Troussard X, Rimokh R, Valensi F, Leboeuf D, Fenneteau O, Guitard AM et al. (1995). Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group. Br J Haematol 89: 516-526.
42. van Dijk MA, Peltenburg LT, Murre C. (1995). Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech Dev 52: 99-108.
43. van Dijk MA, Voorhoeve PM, Murre C. (1993). Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 90: 6061-6065.
44. Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ et al. (2008). The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111: 4668-4680.
45. Zhang XB, Beard BC, Trobridge GD, Wood BL, Sale GE, Sud R et al. (2008). High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J Clin Invest 118: 1502-1510.